Is Bismuth Toxic? Factors and Symptoms of Exposure

Bismuth sits in an unusual place among heavy metals: it is one of the least toxic to humans, yet it can absolutely cause serious harm under the right circumstances. The element is best known as the active ingredient in over-the-counter stomach remedies, and at standard doses, less than one percent of it is absorbed through the gut. Problems arise when people take too much for too long, when bismuth is introduced through non-oral routes, or when the compound it rides in carries its own risks. The gap between “safe at recommended doses” and “dangerous in excess” is wide enough to lull people into complacency, which is exactly how most bismuth poisoning cases happen.

Why Bismuth Is Considered a “Safe” Heavy Metal

Bismuth belongs to the same column of the periodic table as arsenic and antimony, which tends to raise eyebrows. But unlike those neighbors, bismuth compounds have been used medicinally for centuries with a remarkably clean safety record at therapeutic doses. The gastrointestinal absorption rate of bismuth medicines is less than one percent, and the small amount that does get absorbed is rapidly cleared through the kidneys.¹ That extremely low bioavailability is the main reason bismuth subsalicylate (the active ingredient in Pepto-Bismol and similar products) can be sold without a prescription. Most of what you swallow passes straight through you.

The U.S. FDA has estimated a recommended daily intake for bismuth of roughly 848 mg of bismuth per day for gastrointestinal disorders, which translates to about 12 mg per kilogram of body weight.² That ceiling is generous by heavy-metal standards. For context, bismuth compounds are also used in wound dressings, dental materials, and as replacements for lead in ammunition and industrial alloys, partly because of the element’s favorable safety profile relative to other metals in its weight class.

What Happens When Too Much Accumulates

The trouble starts when that less-than-one-percent absorption rate adds up over weeks, months, or years. Bismuth binds readily to tissues once it enters the bloodstream, and it clears from the body far more slowly than older models predicted. A pharmacokinetic study in healthy volunteers found that the volume of distribution of bismuth was vastly greater than total body fluid volume, meaning the metal was binding extensively to organs and tissues. The mean residence time in whole blood was about 22 days, and participants still had measurable bismuth in their bodies 60 days after stopping the drug.³

A separate study using injected radioactive bismuth-207 in humans found that the terminal half-life in the body was about 1.9 years, with about 0.6 percent of the dose still present after 924 days. The liver held the largest organ deposit, containing roughly 60 percent of the body’s bismuth burden after three days.⁴ That finding is worth pausing on. Previous models assumed bismuth left the body with a half-life of just five days and concentrated in the kidneys. The reality is that bismuth lingers in the liver for far longer and at much higher concentrations than previously thought. This slow clearance is why chronic low-level overuse can gradually push someone into toxic territory without any single dramatic overdose event.

Bismuth Encephalopathy

The most dramatic form of bismuth toxicity is neurological. In the 1970s, outbreaks of a reversible neurological disease called bismuth encephalopathy appeared in patients, particularly in France and Australia, who had been taking large doses of bismuth compounds over extended periods. Symptoms included confusion, difficulty walking, tremors, and jerky involuntary movements known as myoclonus. The outbreaks prompted regulatory action, and several countries restricted or reformulated bismuth-containing medications.

Cases still occur. A published report describes a 44-year-old woman who had been taking bismuth subsalicylate for about 20 years and developed abnormal behavior and postural instability over a two-week period. On examination, she had greyish discoloration of her teeth, was confused, and showed generalized myoclonic jerks. Over the following days her condition worsened, with declining alertness and more pronounced involuntary movements.⁵ The good news is that bismuth encephalopathy is generally reversible once the source of bismuth is identified and removed. The bad news is that it is often misdiagnosed at first, because clinicians do not immediately think to ask about over-the-counter antacid use when someone presents with confusion and movement problems.

The characteristic symptoms to watch for include:

Confusion: Disorientation, difficulty concentrating, personality changes
Myoclonus: Sudden, involuntary muscle jerks affecting the limbs or whole body
Postural instability: Unsteady gait, frequent falls, difficulty standing
Greyish discoloration: A darkening of the gums, tongue, or teeth from bismuth sulfide deposits

That last symptom is a useful clinical clue. The grey-black discoloration of oral tissues happens because bismuth reacts with trace amounts of sulfur in saliva and the gut, forming bismuth sulfide. The same reaction is responsible for the temporary black tongue and dark stools that sometimes alarm people taking normal doses of Pepto-Bismol. At standard doses, those color changes are harmless. But extensive, persistent grey discoloration of the gums or teeth in someone with neurological symptoms should prompt an immediate check for bismuth toxicity.

Kidney Damage From Overdose

While encephalopathy gets the most attention, the kidneys are actually the first organs to suffer in an acute bismuth overdose. Animal studies show the damage progression is rapid and specific. In rats given an overdose of colloidal bismuth subcitrate, plasma creatinine (a marker of kidney function) rose from normal levels to roughly ten times normal within 48 hours. The damage targeted a specific segment of the kidney’s filtering tubules first, with cell death visible within one hour and full tissue death within three hours in the most vulnerable segment.⁶

Follow-up research clarified the mechanism of kidney cell death. Rather than triggering the orderly self-destruction process that cells typically use when damaged, bismuth at high concentrations kills kidney cells by direct necrosis, likely by destabilizing the cell membrane itself. The damage happens too fast and too aggressively for the cell’s normal cleanup systems to engage.⁷ This matters practically because it means an acute overdose can cause irreversible kidney damage before the body has any chance to adapt or compensate. Acute bismuth overdose is a medical emergency, not something to wait out.

The Hidden Salicylate Problem

Here is a wrinkle that many people miss entirely: bismuth subsalicylate is not just a bismuth compound. It is also a salicylate, in the same chemical family as aspirin. When you take Pepto-Bismol, you are getting a dose of both bismuth and salicylate. At recommended doses this is fine. But someone who chronically overuses bismuth subsalicylate can develop salicylate toxicity independently of, or alongside, bismuth toxicity. The symptoms overlap in confusing ways.

A case report describes a 79-year-old man who came to the emergency department with a week of worsening confusion, falls, and hearing loss. The initial workup for infections, metabolic problems, and structural brain issues found nothing. It was only when clinicians dug deeper into his medication history that they discovered he had been drinking one to two bottles of Pepto-Bismol daily for reflux symptoms. His plasma salicylate concentration was 2.08 mmol/L, at the upper end of the therapeutic reference range, even after having been in hospital without any salicylate sources for a day.⁸ He was diagnosed with chronic salicylate toxicity and improved after the product was discontinued.

Salicylate toxicity causes tinnitus (ringing in the ears), hearing impairment, confusion, rapid breathing, and metabolic derangements. Some of those symptoms look a lot like early bismuth encephalopathy. In someone overusing bismuth subsalicylate, it can be genuinely difficult to tell whether the problem is bismuth, salicylate, or both. This is why clinicians need to measure both bismuth blood levels and salicylate levels when evaluating a patient with unexplained neurological symptoms and a history of antacid overuse.

How Blood Levels Guide Diagnosis

Bismuth blood levels provide the clearest picture of whether someone is in danger. Based on clinical data, levels below 50 micrograms per liter are unlikely to be associated with meaningful toxicity.⁹ Normal therapeutic use of bismuth compounds produces blood levels well below that threshold. Patients with encephalopathy symptoms typically have levels far above it.

The challenge is that bismuth blood testing is not a routine lab test. Most hospital labs do not run it automatically, and it has to be specifically requested. Since bismuth toxicity is rare and its symptoms mimic more common conditions like dementia, delirium, or infection, the diagnosis often comes late. The greyish discoloration of oral tissues, if present, can serve as a prompt for clinicians to order bismuth levels, but not every case includes that visual cue.

Treatment and Recovery

The first and most important step in treating bismuth toxicity is stopping the bismuth source. For encephalopathy cases, symptoms typically begin improving within days to weeks of discontinuation, though full recovery can take longer given bismuth’s slow clearance from tissues.

In severe cases, chelation therapy can speed the process. A published case of severe bismuth poisoning from a bismuth-containing wound paste (bismuth iodoform paraffin paste, used in surgical packing) documented a pre-chelation bismuth blood concentration of 480 micrograms per liter. After treatment with DMPS, a chelating agent that binds heavy metals and promotes their excretion, the level dropped to 5 micrograms per liter with improvement in symptoms and no adverse effects from the chelation itself.¹⁰ That case is also a reminder that bismuth toxicity does not only come from oral medications. Wound dressings, surgical packing materials, and other medical products containing bismuth compounds can cause toxicity if bismuth is absorbed through damaged tissue.

How Bismuth Protects the Stomach at Normal Doses

Understanding the protective side of bismuth helps clarify why people use these products in the first place and why moderate use has a strong safety record. At the cellular level, bismuth subsalicylate acts as an antioxidant in gastric tissue. Laboratory studies using cultured human stomach cells showed that pretreatment with bismuth subsalicylate reduced ethanol-induced oxidative damage in a dose-dependent manner, cutting markers of cellular oxidative stress by up to about two-thirds at the highest concentration tested.¹¹ The compound also reduced DNA damage from chemical irritants. This gastroprotective effect, combined with antimicrobial activity against the ulcer-causing bacterium H. pylori, explains bismuth’s long track record in treating stomach and intestinal complaints.

The irony is that the same compound that protects stomach cells from damage at low concentrations can destroy kidney cells through membrane disruption at high concentrations. The dose truly makes the poison here, and the margin between therapeutic and toxic is wider for bismuth than for most heavy metals but not infinitely wide.

Bismuth in Ammunition and Wildlife

Outside medicine, bismuth has found a second life as a replacement for lead in shotgun pellets. Lead shot was banned for waterfowl hunting in many countries because birds ingest spent pellets while foraging, leading to lead poisoning. Bismuth-tin shot emerged as one alternative, and waterfowl studies have shown it to be nontoxic to birds that ingest the pellets. However, researchers have urged caution about assuming complete safety when humans consume wild game that may contain embedded bismuth pellet fragments. The concern is not about cooking or eating game in general but about the uncertainty surrounding what happens when whole metallic bismuth pellets or fragments are swallowed and sit in the acidic environment of the human stomach.¹² Metallic bismuth dissolving slowly in stomach acid is a different exposure scenario than taking a measured dose of a pharmaceutical bismuth salt, and less is known about how much bismuth is released in that situation.

Bismuth Nanoparticles and Emerging Medical Uses

Researchers are investigating bismuth nanoparticles as contrast agents for CT scans and X-ray imaging. Bismuth absorbs X-rays very effectively, which makes it a promising alternative to current contrast agents based on iodine or barium. Early laboratory work suggests acceptable biocompatibility. In one study, bismuth nanoparticles showed no decrease in cell viability for one type of human cell line at any concentration tested after 24 hours of exposure, though immune cells (macrophages) did show reduced viability at elevated concentrations with prolonged exposure.¹³

Nanoparticle formulations behave differently from bulk bismuth compounds. Their tiny size gives them much larger surface areas per unit mass, which changes how they interact with cells and how readily they release bismuth ions. Researchers have noted that while the initial biocompatibility data is encouraging, careful in-vivo toxicity studies will be necessary before bismuth nanoparticles move toward clinical use.¹⁴ The field is still early-stage, but if bismuth nanoparticles prove safe and effective, they could significantly expand the medical uses of an element most people currently associate only with pink stomach medicine.

Who Is Most at Risk

Certain groups face higher risk from bismuth toxicity, and recognizing them helps prevent the worst outcomes.

Chronic self-medicators: People who take bismuth subsalicylate daily for years, often for chronic indigestion, reflux, or irritable bowel symptoms, without medical supervision. They gradually accumulate bismuth in tissues without realizing it.
Older adults: Kidney function naturally declines with age, which slows bismuth clearance. Older adults are also more likely to have multiple medications that interact with salicylates, and more likely to have chronic GI complaints that drive long-term antacid use.
People with kidney disease: Since the kidneys are the primary excretion route for absorbed bismuth, anyone with impaired kidney function will clear the metal more slowly and reach toxic levels faster.
Surgical patients: Those receiving bismuth-containing wound packing materials can absorb significant amounts through surgical wounds, bypassing the gut’s protective barrier of low absorption.

The common thread in published case reports is duration, not dose spikes. Most victims of bismuth encephalopathy were not taking wildly excessive amounts on any given day. They were taking moderate-to-high doses over months or years, allowing the metal to slowly accumulate in their brains and other tissues. The long biological half-life of bismuth means that even modest daily intake, if sustained long enough, can eventually overwhelm the body’s ability to clear it.

If you use bismuth subsalicylate occasionally for an upset stomach or traveler’s diarrhea, the risk of toxicity is vanishingly small. If you find yourself reaching for it every day, or going through bottles of it weekly, that pattern deserves a conversation with a doctor, both about the bismuth itself and about whatever underlying digestive problem is driving such heavy use.